Medicare Enrolled
Dr. Murad Arif, MD
Addiction Medicine (Preventive Medicine) Physician · Murrieta, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Arif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arif?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Arif
Dr. Murad Arif is an addiction medicine physician in Murrieta, CA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Arif performed 6,329 Medicare services across 1,704 unique beneficiaries.
Between the years covered by Open Payments, Dr. Arif received a total of $27,825 from 38 pharmaceutical and/or device companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in addiction medicine (preventive medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Arif is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years in practice
▲ Top 8% volume in CA
$27,825 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,329
Medicare services
Top 8% in CA for addiction medicine (preventive medicine) physician
1,704
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~791 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,642 | $104 | $271 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
768 | $5 | $10 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
517 | $0 | $1 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
479 | $12 | $30 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
205 | $43 | $111 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
200 | $49 | $133 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 159 | $38 | $199 |
| Injection, ropivacaine hydrochloride, 1 mg | 145 | $0 | $5 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
135 | $211 | $555 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
134 | $252 | $805 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
134 | $381 | $998 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
113 | $0 | $15 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
75 | $226 | $760 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
75 | $116 | $389 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
74 | $94 | $266 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
59 | $76 | $192 |
| Spinal nerve root injection with imaging guidance An injection of anesthetic or steroid medication into a single nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement. |
46 | $288 | $924 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
42 | $60 | $182 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $138 | $353 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
32 | $224 | $575 |
| New patient office visit, complex (60-74 min) | 32 | $179 | $466 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
32 | $0 | $5 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
30 | $378 | $967 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $112 | $381 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
24 | $201 | $647 |
| Additional spine nerve root injection with imaging An anesthetic and/or steroid medication is injected into an additional nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement. |
21 | $121 | $324 |
| Nerve destruction for spine-pelvis joint pain A procedure that destroys the nerves supplying the joint between the spine and pelvis to relieve pain. Imaging guidance is used to ensure accurate placement. |
18 | $432 | $1,219 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
17 | $89 | $324 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
17 | $235 | $828 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
17 | $124 | $416 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
15 | $223 | $570 |
| Spinal and pelvic nerve injection with imaging guidance An anesthetic and/or steroid medication is injected into nerves in the spine or pelvis while using imaging to guide the needle placement. |
12 | $287 | $970 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$27,825
Total received (2018-2024)
Avg $3,975/year across 7 years
Top 7% in CA for addiction medicine (preventive medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
356
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,607 (52.5%)
Scientific / Research
Research funding and grants
$11,250 (40.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,968 (7.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,189
2023
$3,252
2022
$5,053
2021
$4,031
2020
$1,237
2019
$12,591
2018
$472
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$424
Collegium Pharmaceutical, Inc.
$201
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$196
Valinor Pharma, LLC
$72
Vision Quest Industries Inc.
$68
PFIZER INC.
$62
SCILEX PHARMACEUTICALS INC.
$39
Octapharma USA, Inc.
$37
Virtus Pharmaceuticals LLC
$36
SI-BONE, INC.
$24
Nalu Medical, Inc.
$15
ABBVIE INC.
$14
Top 3 companies account for 69.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$11,250
Medtronic, Inc.
$4,836
Boston Scientific Corporation
$3,091
Biohaven Pharmaceutical Holding Company Ltd.
$1,968
BOSTON SCIENTIFIC CORPORATION
$1,314
Nevro Corp.
$1,038
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$727
Merck Sharp & Dohme Corporation
$594
Collegium Pharmaceutical, Inc.
$549
Curonix LLC
$331
ABBVIE INC.
$304
AbbVie Inc.
$282
IDORSIA PHARMACEUTICALS US INC
$173
Biohaven Pharmaceuticals, Inc.
$140
Flexion Therapeutics, Inc.
$109
PFIZER INC.
$106
SCILEX PHARMACEUTICALS INC.
$101
Mallinckrodt LLC
$100
Avanos Medical
$91
Scilex Pharmaceuticals Inc.
$78
Valinor Pharma, LLC
$72
SI-BONE, INC.
$68
Vision Quest Industries Inc.
$68
Cumberland Pharmaceuticals, Inc.
$66
Stryker Corporation
$45
Stimwave Technologies Incorporated
$40
Octapharma USA, Inc.
$37
Azurity Pharmaceuticals, Inc.
$36
Virtus Pharmaceuticals LLC
$36
Vertos Medical, Inc.
$31
ABIOMED
$24
Pacira Pharmaceuticals Incorporated
$21
PAINTEQ LLC
$21
Indivior Inc.
$18
SI-BONE, Inc.
$17
Fidia Pharma USA Inc.
$17
Nalu Medical, Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 68.9% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · BRIDION · Belbuca · CALDOLOR · COMIRNATY · Exparel · FIBRYGA · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GENERATOR · General - Pain Management · HYMOVIS · Horizant · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Impella · KYPHON EXPRESS II KYPHOPAK TRAY · LEVORPHANOL TARTRATE · MOVANTIK · NURTEC ODT · Nalu Neurostimulation System · OFIRMEV · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRO estim NMES Stimulator · QULIPTA · QUVIVIQ · RELISTOR · SPECTRA WAVEWRITER · SPINEJACK · SUBLOCADE · SUPERION · SYNCHROMED · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w/Receiver · UBRELVY · VANTA ADAPTIVESTIM · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZTLido · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for addiction medicine (preventive medicine) physician in CA.
Geographic Context
Addiction medicine physicians within 10 mi
1
Per 100K population
0.0
County median income
$89,672
Nearest hospital
SOUTHWEST HEALTHCARE RANCHO SPRINGS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Arif is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 7% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Arif experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Arif performed 2,642 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arif receive payments from pharmaceutical companies?
Yes. Dr. Arif received a total of $27,825 from 38 companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arif's costs compare to other addiction medicine physicians in Murrieta?
Dr. Arif's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Addiction Medicine Physicians in Murrieta
Browse addiction medicine physicians in Murrieta ranked by procedure volume and transparency data.
Highest volume
Top Addiction Medicine Physicians in CA
Addiction medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Addiction Medicine Physicians in CA
Which CA addiction medicine physicians receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology